UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 70

Sortiert nach

A phase II study of cetuximab and radiation in elderly and/or poor performance status patients with locally advanced non-small-cell lung cancer (N0422)

Annals of oncology, 2010-10, Vol.21 (10), p.2040-2044

2010

Volltextzugriff (PDF)

Suppression of SCARA5 by Snail1 is essential for EMT-associated cell migration of A549 cells

Oncogenesis (New York, NY), 2013-09, Vol.2 (9), p.e73-e73

2013

Volltextzugriff (PDF)

Severe neutropenia associated with oral terbinafine therapy

Journal of the American Academy of Dermatology, 1998-05, Vol.38 (5), p.765-767

1998

Volltextzugriff (PDF)

Phase III evaluation of nortriptyline for alleviation of symptoms of cis-platinum-induced peripheral neuropathy

Pain (Amsterdam), 2002-07, Vol.98 (1), p.195-203

2002

Volltextzugriff (PDF)

Adjuvant Chemotherapy in Older Women with Early-Stage Breast Cancer

The New England journal of medicine, 2009-05, Vol.360 (20), p.2055-2065

2009

Volltextzugriff (PDF)

Eosinophilia associated with bupropion

The Annals of pharmacotherapy, 1995-09, Vol.29 (9), p.867

1995

Volltextzugriff (PDF)

Capecitabine and Oxaliplatin in the Preoperative Multimodality Treatment of Rectal Cancer: Surgical End Points From National Surgical Adjuvant Breast and Bowel Project Trial R-04

Journal of clinical oncology, 2014-06, Vol.32 (18), p.1927-1934

2014

Volltextzugriff (PDF)

Systemic polyclonal B-immunoblastic proliferation with marked peripheral blood and bone marrow plasmacytosis

American journal of clinical pathology, 1992-08, Vol.98 (2), p.222-226

1992

Volltextzugriff (PDF)

Continuous-Infusion Floxuridine and Alpha Interferon in Metastatic Renal Cancer: A National Biotherapy Study Group Phase II Study

Cancer investigation, 1999, Vol.17 (6), p.379-384

1999

Volltextzugriff (PDF)

Efficacy of gabapentin in the management of chemotherapy-induced peripheral neuropathy : A phase 3 randomized, double-blind, placebo-controlled, crossover trial (NOOC3)

Cancer, 2007-11, Vol.110 (9), p.2110-2118

2007

Volltextzugriff (PDF)

81 SUBCUTANEOUS INTERLEUKIN-4 FOR RELAPSED NON-HODGKIN'S LYMPHOMA: A PHASE II TRIAL IN THE NORTH CENTRAL CANCER TREATMENT GROUP, NCCTG 91-78-51

Journal of investigative medicine, 2007-03, Vol.55 (2), p.S362-S362

2007

Volltextzugriff (PDF)

Comparative Economics of a 12-Gene Assay for Predicting Risk of Recurrence in Stage II Colon Cancer

PharmacoEconomics, 2014-12, Vol.32 (12), p.1231-1243

2014

Volltextzugriff (PDF)

Paclitaxel-associated acute pain syndrome (P-APS) and its association on the development of peripheral neuropathy: NCCTG trial N08C1

Journal of clinical oncology, 2011-05, Vol.29 (15_suppl), p.9047-9047

2011

Volltextzugriff (PDF)

Natural history of paclitaxel-associated acute pain syndrome (P-APS): NCCTG trial N08C1

Journal of clinical oncology, 2010-05, Vol.28 (15_suppl), p.9135-9135

2010

Volltextzugriff (PDF)

Abstract S1-05: A randomized, double-blinded, placebo-controlled clinical trial of extended adjuvant endocrine therapy (tx) with letrozole (L) in postmenopausal women with hormone-receptor (+) breast cancer (BC) who have completed previous adjuvant tx with an aromatase inhibitor (AI): Results from NRG Oncology/NSABP B-42

Cancer research (Chicago, Ill.), 2017-02, Vol.77 (4_Supplement), p.S1-S1-05

2017

Volltextzugriff (PDF)

Abstract S1-02: PrECOG 0102: A randomized, double-blind, phase II trial of fulvestrant plus everolimus or placebo in post-menopausal women with hormone receptor (HR)-positive, HER2-negative metastatic breast cancer (MBC) resistant to aromatase inhibitor (AI) therapy

Cancer research (Chicago, Ill.), 2017-02, Vol.77 (4_Supplement), p.S1-S1-02

2017

Volltextzugriff (PDF)

The impact of capecitabine and oxaliplatin in the preoperative multimodality treatment in patients with carcinoma of the rectum: NSABP R-04

Journal of clinical oncology, 2011-05, Vol.29 (15_suppl), p.3503-3503

2011

Volltextzugriff (PDF)

Abstract S6-04: Patient-reported outcome (PRO) results, NRG Oncology/NSABP B-35: A clinical trial of anastrozole (A) vs tamoxifen (tam) in postmenopausal patients with DCIS undergoing lumpectomy plus radiotherapy

Cancer research (Chicago, Ill.), 2016-02, Vol.76 (4_Supplement), p.S6-S6-04

2016

Volltextzugriff (PDF)

A prospective study of patient accrual to clinical trials at a NCI-funded Community Clinical Oncology Program

Journal of clinical oncology, 2008-05, Vol.26 (15_suppl), p.9610-9610

2008

Volltextzugriff (PDF)

Chemo-biotherapy with 5-fluorouracil, leucovorin, and alpha interferon in metastatic carcinoma of the colon--a Cancer Biotherapy Research Group [CBRG] phase II study

Cancer biotherapy & radiopharmaceuticals, 2000-04, Vol.15 (2), p.175-183

2000

Volltextzugriff (PDF)

A pilot, multi-dose, placebo-controlled evaluation of american ginseng (panax quinquefolius) to improve cancer-related fatigue: NCCTG trial N03CA

Journal of clinical oncology, 2007-06, Vol.25 (18_suppl), p.9001-9001

2007

Volltextzugriff (PDF)

Baseline quality of life (QOL) as a prognostic factor for overall survival (OS) in patients (Pts) with advanced stage non-small cell lung cancer (A-NSCLC): An analysis of NCCTG studies

Journal of clinical oncology, 2008-05, Vol.26 (15_suppl), p.8076-8076

2008

Volltextzugriff (PDF)

Abstract P1-12-06: N0937 (Alliance): Preliminary results of a phase II clinical trial of cisplatin and the novel agent brostallicin in patients with metastatic triple negative breast cancer (mTNBC)

Cancer research (Chicago, Ill.), 2012-12, Vol.72 (24_Supplement), p.P1-P1-12-06

2012

Volltextzugriff (PDF)

Topotecan Is an Active Agent in the First-Line Treatment of Metastatic or Recurrent Endometrial Carcinoma: Eastern Cooperative Oncology Group Study E3E93

Journal of clinical oncology, 2003-06, Vol.21 (11), p.2110-2114

2003

Volltextzugriff (PDF)

N0234: Phase II study of erlotinib (OSI-774) plus gemcitabine as first-or second-line therapy for metastatic breast cancer (MBC)

Journal of clinical oncology, 2005-06, Vol.23 (16_suppl), p.644-644

2005

Volltextzugriff (PDF)

1 – 25 von 70

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(67)
Mit Volltextzugriff
(62)

Publikationsform

Artikel
(68)
Tagungsberichte
(2)

Sprache

Englisch
(70)
Japanisch
(7)

Erscheinungsjahr

n.n

Thema

Science & Technology
(46)
Humans
(44)
Life Sciences & Biomedicine
(44)
Female
(36)
Male
(33)
Middle Aged
(33)
Biological And Medical Sciences
(26)
Medical Sciences
(26)
Aged
(25)
Adult
(24)
Oncology
(21)
Chemotherapy
(11)
Pharmacology. Drug Treatments
(11)
Aged, 80 And Over
(10)
Antineoplastic Combined Chemotherapy Protocols - Adverse Effects
(10)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(10)
Survival Rate
(10)
Treatment Outcome
(10)
Antineoplastic Agents
(9)
Double-Blind Method
(9)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

A phase II study of cetuximab and radiation in elderly and/or poor performance status patients with locally advanced non-small-cell lung cancer (N0422)

Suppression of SCARA5 by Snail1 is essential for EMT-associated cell migration of A549 cells

Severe neutropenia associated with oral terbinafine therapy

Phase III evaluation of nortriptyline for alleviation of symptoms of cis-platinum-induced peripheral neuropathy

Adjuvant Chemotherapy in Older Women with Early-Stage Breast Cancer

Eosinophilia associated with bupropion

Capecitabine and Oxaliplatin in the Preoperative Multimodality Treatment of Rectal Cancer: Surgical End Points From National Surgical Adjuvant Breast and Bowel Project Trial R-04

Systemic polyclonal B-immunoblastic proliferation with marked peripheral blood and bone marrow plasmacytosis

Continuous-Infusion Floxuridine and Alpha Interferon in Metastatic Renal Cancer: A National Biotherapy Study Group Phase II Study

Efficacy of gabapentin in the management of chemotherapy-induced peripheral neuropathy : A phase 3 randomized, double-blind, placebo-controlled, crossover trial (NOOC3)

81 SUBCUTANEOUS INTERLEUKIN-4 FOR RELAPSED NON-HODGKIN'S LYMPHOMA: A PHASE II TRIAL IN THE NORTH CENTRAL CANCER TREATMENT GROUP, NCCTG 91-78-51

Comparative Economics of a 12-Gene Assay for Predicting Risk of Recurrence in Stage II Colon Cancer

Paclitaxel-associated acute pain syndrome (P-APS) and its association on the development of peripheral neuropathy: NCCTG trial N08C1

Natural history of paclitaxel-associated acute pain syndrome (P-APS): NCCTG trial N08C1

Abstract S1-02: PrECOG 0102: A randomized, double-blind, phase II trial of fulvestrant plus everolimus or placebo in post-menopausal women with hormone receptor (HR)-positive, HER2-negative metastatic breast cancer (MBC) resistant to aromatase inhibitor (AI) therapy

The impact of capecitabine and oxaliplatin in the preoperative multimodality treatment in patients with carcinoma of the rectum: NSABP R-04

Abstract S6-04: Patient-reported outcome (PRO) results, NRG Oncology/NSABP B-35: A clinical trial of anastrozole (A) vs tamoxifen (tam) in postmenopausal patients with DCIS undergoing lumpectomy plus radiotherapy

A prospective study of patient accrual to clinical trials at a NCI-funded Community Clinical Oncology Program

Chemo-biotherapy with 5-fluorouracil, leucovorin, and alpha interferon in metastatic carcinoma of the colon--a Cancer Biotherapy Research Group [CBRG] phase II study

A pilot, multi-dose, placebo-controlled evaluation of american ginseng (panax quinquefolius) to improve cancer-related fatigue: NCCTG trial N03CA

Baseline quality of life (QOL) as a prognostic factor for overall survival (OS) in patients (Pts) with advanced stage non-small cell lung cancer (A-NSCLC): An analysis of NCCTG studies

Abstract P1-12-06: N0937 (Alliance): Preliminary results of a phase II clinical trial of cisplatin and the novel agent brostallicin in patients with metastatic triple negative breast cancer (mTNBC)

Topotecan Is an Active Agent in the First-Line Treatment of Metastatic or Recurrent Endometrial Carcinoma: Eastern Cooperative Oncology Group Study E3E93

N0234: Phase II study of erlotinib (OSI-774) plus gemcitabine as first-or second-line therapy for metastatic breast cancer (MBC)

Suchergebnisse filtern